Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries.
Varsha HandeNilesh RanjanSupriya ChopraShwetabh SinhaPrachi MittalAnkita GuptaAmita MaheshwariSudeep GuptaPublished in: JCO global oncology (2024)
Although the initial costs of IG-IMRT are high, on the basis of longitudinal data, it is financially inefficient to treat with 3D-CRT. Resource-stratified guidelines should include longitudinal health intervention costs rather than solely initial costs for policy decisions to implement advanced radiation technology.
Keyphrases
- phase iii
- radiation therapy
- clinical trial
- public health
- healthcare
- open label
- cross sectional
- mental health
- randomized controlled trial
- phase ii
- radiation induced
- study protocol
- placebo controlled
- big data
- health information
- risk assessment
- machine learning
- human health
- left ventricular
- cardiac resynchronization therapy